Spyre Therapeutics (SYRE) FCF Margin Growth (1y) (2016 - 2023)
Spyre Therapeutics (SYRE) FCF Margin Growth (1y) (2016 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,187.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Spyre Therapeutics | 257.83 Mn | 257.83 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 88,864.00 |
| Mar 31, 2023 | -697,508.00 |
| Dec 31, 2022 | -1.03 Mn |
| Sep 30, 2022 | -851,790.00 |
| Jun 30, 2022 | -332,266.00 |
| Jun 30, 2018 | 2,308.00 |
| Mar 31, 2018 | 8,208.00 |
| Dec 31, 2017 | -5,317.00 |
| Sep 30, 2017 | -8,266.00 |
| Jun 30, 2017 | -6,102.00 |
| Mar 31, 2017 | -11,626.00 |
| Dec 31, 2016 | -30,065.00 |
| Sep 30, 2016 | -14,614.00 |
| Jun 30, 2016 | -23,118.00 |